A Phase III, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Long-Term Triple Combination Therapy With Azilsartan, Amlodipine, and Hydrochlorothiazide in Patients With Essential Hypertension

Blood Pressure - United Kingdom
doi 10.1080/08037051.2017.1412797
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Long-Term Efficacy of Combination Therapy With Losartan and Low-Dose Hydrochlorothiazide in Patients With Uncontrolled Hypertension

International Heart Journal
MedicineCardiovascular MedicineCardiology
2007English

Efficacy of Fixed Dose of Triple Combination of Perindopril-Indapamide-Amlodipine in Obese Patients With Moderate-To-Severe Arterial Hypertension: An Open-Label 6-Month Study

Biomedical Research and Therapy
BiochemistryMedicineGeneticsMolecular Biology
2019English

Long-Term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-Center, Open-Label, Phase IIIb Study

Clinical Therapeutics
Pharmacology
2016English

An Open Label Study to Evaluate Safety and Efficacy of Unex® Capsules in Patients With Urinary Disorders

Journal of Ayurveda Medical Sciences
2018English

A Phase III, Multicenter, Collaborative, Open-Label Clinical Trial of Sildenafil in Japanese Patients With Pulmonary Arterial Hypertension

Circulation Journal
MedicineCardiovascular MedicineCardiology
2011English

Effectiveness of Open-Label Losartan/Hydrochlorothiazide Combination Therapy in Asian Patients With Hypertension Not Controlled With ACE Inhibitor or ARB Monotherapy

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2009English

Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual-Combination Therapy

Journal of Clinical Hypertension
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2015English

Efficacy of Fixed-Dose Amlodipine and Losartan Combination Compared With Amlodipine Monotherapy in Stage 2 Hypertension: A Randomized, Double Blind, Multicenter Study

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2011English

A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy